Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/96585100-5e98-49f2-871c-60c80f76fd10/
TGTX
TG Therapeutics IncSnapshot 2026-06-07 · 0.0w · Fresh
Strategy Eligibility
1 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
Yes
▣
Piotroski Bargains
✗
🔬
Quality Compounders
✗
📈
Consistent Earners
✗
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
8.0%ile
P/E
13.9×
P/S
9.2×
P/B
11.0×
E/P
0.0719
FCF Yield
-0.002
EBITDA/EV
0.023
SH Yield
0.000
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
89.00000000
/100 — 1=cheapest
VC2 (Trending Value)
92.00000000
/100
VC3 (Buyback)
92.00000000
/100
Negative FCF yield (-0.2%) — the business is currently cash-consumptive. VC2 score of 92.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
32.0%ile
ROE
0.792
ROA
0.302
Net Margin
0.660
Op Margin
0.224
GPA
0.380
D/E
1.62
Current
5.81
F-Score
4/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.813
Stability
2.123
lower=better
Accruals
0.311
lower=better
5yr Consist
No
ROE of 79% is exceptional. Accruals ratio of 0.311 is elevated — earnings quality may be lower than headline numbers suggest.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
24.0%ile
6M Return
30.6%
12M Return
0.2%
12-1 Mom
7.0%
Risk-Adj
0.14
Vol 252d
49.0%
Vol 60d
102.4%
↑ Expanding
Max DD 12M
-29.5%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (102%) is expanding vs long-term (49%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.03
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
2.4%
Sector Quality %ile
10.2%
P/E z-score
-0.21
P/B z-score
0.50
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Growth at Reasonable Price
Revenue growing 81% with P/E of 14×. Growth isn't fully priced in.
Earnings Quality Concern
ROE looks strong (79%) but high accruals (0.311) suggests earnings are accrual-heavy, not cash-backed.
Volatility Expanding
60-day vol (102%) significantly exceeds 252-day (49%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
F
29.0% avg (7 factors)
Quality
A
76.7% avg (8 factors)
Momentum
C
45.2% avg (4 factors)
Risk
D
35.0% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution. Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.030 | —1 | — | |
| Value %ile | 0.080 | —1 | — | |
| Quality %ile | 0.320 | —0 | — | |
| Momentum %ile | 0.240 | —1 | — | |
| F-Score | 4.000 | —1 | — | |
| Confidence | 0.970 | —1 | — | |
| Volatility | 0.490 | —1 | — |
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
13.92
Earnings Yield (E/P)
0.0719
Price / Sales
9.18
Price / Book
11.02
FCF Yield
-0.2%
EBITDA / EV
2.3%
Sales Yield (1/P·S)
0.1040
Shareholder Yield
Div + net buyback / mktcap
0.0%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
79.2%
Return on Assets
30.2%
Net Margin
66.0%
Operating Margin
22.4%
Gross Profit / Assets
Novy-Marx GPA
38.0%
Debt / Equity
1.62
Current Ratio
5.81
Accruals Ratio
(NI-OCF)/Assets — lower=better
0.311
MomentumPrice trend strength over different horizons
6M Return
30.6%
12M Return
0.2%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
7.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.14
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
81.3%
Earnings Stability (CV)
Lower = more stable
2.123
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
4
Dividend Yield
0.0%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
89
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
92
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
92
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
Yes
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity